Skip to Content
Stock Analyst Update

Altria's Interest in Juul Is a Little Late

The wide-moat tobacco giant may take a stake in the U.S. vaping startup, but we have reservations about the timing of the deal and potential valuation.

Mentioned:

 Altria (MO) is in talks to acquire a "significant minority" stake in U.S. vaping startup Juul Labs, according to a report in The Wall Street Journal. We are not at all surprised by this development, but we have reservations over the timing of the deal and potential valuation. We are retaining our $64 fair value estimate for Altria until any deal is announced.

Despite its wide moats, which relate to brand equity in the cigarette business, Big Tobacco has lost the battle in the U.S. vaping category to Juul. The Juul device was launched in 2015 and since then, sales have skyrocketed. According to Nielsen data cited by CNBC, the company held a 75% share of the U.S. vaping market in the four weeks ended Oct. 6, 2018. In aggregate, Altria, British American Tobacco, and Imperial Brands commanded a share of 22%. The success of Juul is not only taking share from the cigarette makers in vaping, but it is also nibbling away at volumes in their cigarette businesses. The U.S. cigarette market is on course to decline by 4.5% this year, an acceleration of almost a percentage point versus its decline rate of just a few years ago.

Acquiring a stake in Juul is, arguably, a no-brainer for Altria, because if these trends continue, the equity income growth will shield some of its earnings from category share loss. We think there are legitimate questions over the timing and valuation of the deal, however. If the recently announced measures to implement tighter age verification at the point of sale do not slow the rate of teenage nicotine consumption, we would expect the FDA to impose more Draconian measures on vaping products. This would have a negative impact on Juul, whose astonishing growth has coincided with the recent rise in vaping product consumption among school children. The FDA recently cited data from the 2018 National Youth Tobacco Survey indicating there was a 78% increase in the number of U.S. high school children using e-cigarettes in 2017-2018 over the year-ago period.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Philip Gorham does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.